| 1 |
32970317 | Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation. | 2021 Feb |
1 |
| 2 |
31778791 | FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia. | 2020 Jan |
1 |
| 3 |
30798051 | Lead optimization and biological evaluation of fragment-based cN-II inhibitors. | 2019 Apr 15 |
3 |
| 4 |
27906612 | Stably transfected adherent cancer cell models with decreased expression of 5'-nucleotidase cN-II. | 2016 Dec |
1 |
| 5 |
25656700 | The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor. | 2015 Mar 15 |
1 |
| 6 |
25998135 | Determination of the enzymatic activity of cytosolic 5'-nucleotidase cN-II in cancer cells: development of a simple analytical method and related cell line models. | 2015 Jul |
1 |
| 7 |
26079827 | Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II. | 2015 Aug |
1 |
| 8 |
26462774 | [NT5C2 expression in children with acute leukemia and its clinical significance]. | 2015 Sep |
1 |
| 9 |
24607586 | Structure-activity relationships of β-hydroxyphosphonate nucleoside analogues as cytosolic 5'-nucleotidase II potential inhibitors: synthesis, in vitro evaluation and molecular modeling studies. | 2014 Apr 22 |
2 |
| 10 |
23220537 | Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening. | 2013 Feb 15 |
1 |
| 11 |
23377281 | Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. | 2013 Mar |
1 |
| 12 |
23992314 | Therapeutic perspectives for cN-II in cancer. | 2013 |
1 |
| 13 |
21712425 | Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia. | 2011 Oct |
1 |
| 14 |
22174667 | Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues. | 2011 Dec |
1 |
| 15 |
20205377 | Ag(+)-mediated assembly of 5'-guanosine monophosphate. | 2010 Apr 1 |
1 |
| 16 |
21029378 | Active and regulatory sites of cytosolic 5'-nucleotidase. | 2010 Dec |
1 |
| 17 |
16629121 | F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation. | 2006 Mar |
1 |
| 18 |
18404470 | Recent advances in structure and function of cytosolic IMP-GMP specific 5'-nucleotidase II (cN-II). | 2006 Nov |
2 |
| 19 |
15946667 | Regulation and activity of cytosolic 5'-nucleotidase II. A bifunctional allosteric enzyme of the Haloacid Dehalogenase superfamily involved in cellular metabolism. | 2005 Jun 20 |
2 |
| 20 |
12907246 | Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy. | 2003 Aug 1 |
1 |
| 21 |
12916861 | Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies. | 2003 Jul |
1 |
| 22 |
87197 | Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors. | 1979 Apr 1 |
1 |